Implementation of a Pragmatic Trial of Whole Health Team vs. Primary Care Group Education to Promote Non-Pharmacological Strategies to Improve Pain, Function and Quality of Life in Veterans
实施整体健康团队与初级保健团体教育的务实试验,以促进非药物策略,改善退伍军人的疼痛、功能和生活质量
基本信息
- 批准号:10222866
- 负责人:
- 金额:$ 14.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-01-20 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:AccelerometerAnalgesicsCaringChronicChronic DiseaseClinicalCommunicationData CollectionDevelopmentDisease ManagementDoseEducationEffectivenessEnrollmentEvaluationFeedbackFoundationsFundingGeographyGoalsHealthHealth PlanningHealth ServicesHealth care facilityHuman ResourcesInfrastructureIntegrative MedicineInternetInterventionMental HealthMilitary PersonnelMissionModalityModelingMonitorMotivationOpioidPainPain managementPatient EducationPatient Outcomes AssessmentsPatientsPharmaceutical PreparationsPharmacistsPhasePopulationPreparationPrimary Health CareProcessProviderPsyche structurePsychologistQuality of lifeRandomizedRandomized Controlled TrialsResearchResearch PersonnelResourcesRiskSafetyServicesSeveritiesSiteSleep DisordersStructureSuicideSymptomsTechniquesTestingTrainingTraining and EducationTraumaUnited States National Institutes of HealthVeteransWarWristadverse outcomearmbudget impactcare deliverycare providerschronic paincollaboratorycomorbiditycomparative effectiveness trialdisabilityeffectiveness implementation trialevidence baseexperienceformative assessmenthigh riskimprovedimproved functioningin vivo monitoringinnovationmobile applicationmotivational enhancement therapymultimodalitynon-opioid analgesicopioid therapyopioid usepain reductionpain self-managementpain symptompeerphysical therapistpoint of carepragmatic trialprimary care servicesprimary outcomeresponseshared decision makingtooltreatment as usualusual care arm
项目摘要
7. PROJECT SUMARY ABSTRACT
The overarching goal of this Pain Management Collaboratory Demonstration project is to implement a new
Whole Health paradigm for chronic pain care, emphasizing non-pharmacologic pain self-management that
reduces pain symptoms and improves overall functioning and quality of life in veterans. The objective of this
UG3/UH3 proposal is to develop and pilot components that will be used to support a pragmatic
implementation-effectiveness trial of two pain care delivery approaches that differ in structure,
comprehensiveness, and intensity. During the trial phase, over 600 veterans across 4 geographically diverse
VA health care facilities with moderate to severe chronic pain (irrespective of chronic opioid therapy) will be
randomized to receive an intensive Whole Health Team (WHT) versus a less intensive usual care Primary
Care Group Education (PC-GE) approach. All enrolled veterans will be followed for 12 months. In preparation
for the trial, specific aims of the 2-year UG3 phase include: UG3 Aim 1: to use an evidence-based
implementation framework to conduct a formative evaluation that engages trial stakeholders at the 4 VA
enrolling sites, solicits feedback on specific trial components, and identifies barriers to and facilitators of trial
implementation, and UG3 Aim 2: to use stakeholder input to adapt, pilot and refine key components for the
successful implementation of the pragmatic trial including: non-pharmacologic multi-modal pain self-
management education for patients and providers, point-of-care data collection applications, patient reported
measures sensitive to whole health interventions, wrist-worn activity monitors, and web/mobile applications to
support in vivo monitoring of activity and pain and to provide tools for pain self-management. Assuming
transition to the 4-year trial UH3 phase, we will implement these components refined in the UG3 phase. In UH3
Aim 1 we will conduct a 12-month pragmatic effectiveness trial to test whether veterans with moderate to
severe chronic pain randomized to receive the Whole Health Team (WHT) intervention are more likely than
those receiving Primary Care Group Education (PC-GE) to: H1: Experience improved pain severity and
interference, functioning and quality of life (primary outcome); H2: Decrease use of higher risk pain
medications, including opioids, or high risk combinations (secondary); H3: Engage in a greater number of non-
pharmacological pain management activities (secondary); H4: Experience improved comorbid mental health
symptoms, including sleep problems and suicidality. UH3 Aim 2 is to conduct a process evaluation and budget
impact analysis of the implementation of the two interventions to support the development of an
implementation toolkit for scaling and dissemination. Results of this UG3/UH3 Pain Management Collaboratory
Demonstration project will contribute to the overall mission of the NIH/VA/DoD initiative to build national-level
infrastructure that supports non-pharmacologic pain management in veterans and military service personnel.
7.项目总结摘要
此疼痛管理协作实验室演示项目的总体目标是实施一个新的
慢性疼痛护理的整体健康范式,强调非药物疼痛自我管理
减少疼痛症状,改善退伍军人的整体功能和生活质量。这样做的目的是
UG3/UH3建议是开发和试点组件,将用于支持一个务实的
两种结构不同的疼痛护理提供方法的实施-效果试验,
全面性和强度。在试验阶段,来自4个不同地理位置的600多名退伍军人
有中度到重度慢性疼痛的退伍军人管理局卫生保健设施(无论慢性阿片类药物治疗)将
随机接受强化整体卫生团队(WHT)与非强化普通初级护理
关爱团体教育(PC-GE)方法。所有注册的退伍军人将被跟踪12个月。正在准备中
对于试验,为期2年的UG3阶段的具体目标包括:UG3目标1:使用以证据为基础的
实施框架,以进行形成性评估,让4VA的试验利益相关者参与进来
注册网站,征求对特定试验组件的反馈,并确定试验的障碍和促进者
实施和UG3目标2:使用利益攸关方的意见来调整、试点和完善关键组件
成功实施的务实试验包括:非药理学多模式疼痛自评
针对患者和提供者的管理教育、护理点数据收集应用程序、患者报告
对整体健康干预、手腕活动监测器和网络/移动应用程序敏感的措施
支持活体监测活动和疼痛,并为疼痛自我管理提供工具。假设
过渡到为期4年的UH3试验阶段,我们将在UG3阶段实施这些改进的组件。在UH3中
目标1我们将进行为期12个月的务实有效性试验,以测试中度至
严重慢性疼痛随机接受整体健康团队(WHT)干预的可能性比
接受初级护理团体教育(PC-GE)的人:H1:体验更好的疼痛严重程度和
干预、功能和生活质量(主要结果);H2:减少高风险疼痛的使用
药物,包括阿片类药物,或高风险组合(次要);H3:参与更多的非
药理疼痛管理活动(次级);H4:体验改善共病心理健康
症状,包括睡眠问题和自杀。UH3目标2是进行流程评估和预算
两项干预措施的实施影响分析
用于扩展和传播的实施工具包。UG3/UH3疼痛管理合作实验室的结果
示范项目将有助于NIH/VA/DoD倡议的总体使命,即建立国家级
支持退伍军人和军人非药理性疼痛管理的基础设施。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM C BECKER其他文献
WILLIAM C BECKER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM C BECKER', 18)}}的其他基金
Multilevel Interventions to Reduce Harm and Improve Quality of Life for Patients on Long Term Opioid Therapy - Yale Resource Center (MIRHIQL-YRC)
多层次干预措施可减少长期阿片类药物治疗患者的伤害并提高其生活质量 - 耶鲁大学资源中心 (MIRHIQL-YRC)
- 批准号:
10722768 - 财政年份:2023
- 资助金额:
$ 14.26万 - 项目类别:
HD2A Research Adoption Support Center (RASC)
HD2A 研究采用支持中心 (RASC)
- 批准号:
10708980 - 财政年份:2022
- 资助金额:
$ 14.26万 - 项目类别:
Role of Non-pharmacological Pain Treatments in Safe and Effective Opioid Tapering in Chronic Pain
非药物疼痛治疗在安全有效地逐渐减少慢性疼痛中阿片类药物的作用
- 批准号:
10620195 - 财政年份:2022
- 资助金额:
$ 14.26万 - 项目类别:
HD2A RASC - Pain Implementation Support Core
HD2A RASC - 疼痛实施支持核心
- 批准号:
10596438 - 财政年份:2022
- 资助金额:
$ 14.26万 - 项目类别:
HD2A Research Adoption Support Center (RASC)
HD2A 研究采用支持中心 (RASC)
- 批准号:
10596435 - 财政年份:2022
- 资助金额:
$ 14.26万 - 项目类别:
HD2A RASC - Pain Implementation Support Core
HD2A RASC - 疼痛实施支持核心
- 批准号:
10708984 - 财政年份:2022
- 资助金额:
$ 14.26万 - 项目类别:
HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers
HEAL 计划:慢性疼痛和 OUD 整体康复综合管理 (IMPOWR):研究中心
- 批准号:
10876682 - 财政年份:2021
- 资助金额:
$ 14.26万 - 项目类别:
HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers
HEAL 计划:慢性疼痛和 OUD 整体康复综合管理 (IMPOWR):研究中心
- 批准号:
10652027 - 财政年份:2021
- 资助金额:
$ 14.26万 - 项目类别:
HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers
HEAL 计划:慢性疼痛和 OUD 整体康复综合管理 (IMPOWR):研究中心
- 批准号:
10378910 - 财政年份:2021
- 资助金额:
$ 14.26万 - 项目类别:
Implementation of a Pragmatic Trial of Whole Health Team vs. Primary Care Group Education to Promote Non-Pharmacological Strategies to Improve Pain, Function and Quality of Life in Veterans
实施整体健康团队与初级保健团体教育的务实试验,以促进非药物策略,改善退伍军人的疼痛、功能和生活质量
- 批准号:
10090568 - 财政年份:2020
- 资助金额:
$ 14.26万 - 项目类别:
相似海外基金
Planning Study for the Development of Sigma 2 ligands as Analgesics
Sigma 2 配体镇痛药开发规划研究
- 批准号:
10641500 - 财政年份:2023
- 资助金额:
$ 14.26万 - 项目类别:
Designing and validating optimal nonaddictive analgesics using the CANDO paradigm
使用 CANDO 范式设计和验证最佳的非成瘾性镇痛药
- 批准号:
10485593 - 财政年份:2023
- 资助金额:
$ 14.26万 - 项目类别:
Identification of botanical hHv1 channel blockers as analgesics for neuropathic pain
植物 hHv1 通道阻滞剂作为神经性疼痛镇痛药的鉴定
- 批准号:
10728526 - 财政年份:2023
- 资助金额:
$ 14.26万 - 项目类别:
Development of LPA5 Antagonists as Analgesics
LPA5 拮抗剂镇痛药的开发
- 批准号:
10638278 - 财政年份:2023
- 资助金额:
$ 14.26万 - 项目类别:
Designed Multiple Ligands as Non-opioid Analgesics for Treating Chronic Pain
设计多种配体作为非阿片类镇痛药,用于治疗慢性疼痛
- 批准号:
10621646 - 财政年份:2023
- 资助金额:
$ 14.26万 - 项目类别:
Elucidation of the mechanism of pain suppression by exercise and development of new analgesics
阐明运动镇痛机制及开发新型镇痛药
- 批准号:
22K19602 - 财政年份:2022
- 资助金额:
$ 14.26万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
- 批准号:
10425794 - 财政年份:2022
- 资助金额:
$ 14.26万 - 项目类别:
Allosteric Targeting of Cannabinoid CB1 Receptor to Develop Non-Addictive Small Molecule Analgesics
大麻素 CB1 受体变构靶向开发非成瘾性小分子镇痛药
- 批准号:
10512672 - 财政年份:2022
- 资助金额:
$ 14.26万 - 项目类别:
A novel clinically-relevant mouse model of chronic overlapping pain conditions for screening analgesics
用于筛选镇痛药的新型临床相关慢性重叠疼痛小鼠模型
- 批准号:
10821681 - 财政年份:2022
- 资助金额:
$ 14.26万 - 项目类别:
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
- 批准号:
10721752 - 财政年份:2022
- 资助金额:
$ 14.26万 - 项目类别:














{{item.name}}会员




